ID

14780

Descripción

A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01); ODM derived from: https://clinicaltrials.gov/show/NCT00520637

Link

https://clinicaltrials.gov/show/NCT00520637

Palabras clave

  1. 27/4/16 27/4/16 -
Subido en

27 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Advanced Solid Tumors NCT00520637

Eligibility Advanced Solid Tumors NCT00520637

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed diagnosis of advanced and/or metastatic solid tumor or lymphoma that is refractory to standard therapy
Descripción

solid tumor or lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0280100
UMLS CUI [2]
C0024299
measurable or evaluable disease
Descripción

measurable or evaluable disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
score of 0 to 2 on the ecog performance scale
Descripción

ecog

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
concurrent serious medical illness
Descripción

medical illness

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0262926
known, clinically suspected, or history of central nervous system (cns) tumor involvement
Descripción

central nervous system (cns) tumor involvement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085136
active diarrhea
Descripción

active diarrhea

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011991
known history of coagulation disorder
Descripción

coagulation disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005779
patients requiring cytochrome p450 3a4 (cyp3a4) enzyme inducing medications
Descripción

cytochrome p450 3a4

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3830625
requirement for ketoconazole or other strong inhibitor of cyp3a4 enzymes
Descripción

ketoconazole

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0022625
prior chemotherapy, immunotherapy, investigational agent, or other therapy used to treat the cancer within 4 weeks (6 weeks for prior treatment with mitomycin c or nitrosoureas) prior to the scheduled administration of ezn-2208
Descripción

chemotherapy, immunotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0021083

Similar models

Eligibility Advanced Solid Tumors NCT00520637

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
solid tumor or lymphoma
Item
histologically or cytologically confirmed diagnosis of advanced and/or metastatic solid tumor or lymphoma that is refractory to standard therapy
boolean
C0280100 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
measurable or evaluable disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
ecog
Item
score of 0 to 2 on the ecog performance scale
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
medical illness
Item
concurrent serious medical illness
boolean
C0262926 (UMLS CUI [1])
central nervous system (cns) tumor involvement
Item
known, clinically suspected, or history of central nervous system (cns) tumor involvement
boolean
C0085136 (UMLS CUI [1])
active diarrhea
Item
active diarrhea
boolean
C0011991 (UMLS CUI [1])
coagulation disorder
Item
known history of coagulation disorder
boolean
C0005779 (UMLS CUI [1])
cytochrome p450 3a4
Item
patients requiring cytochrome p450 3a4 (cyp3a4) enzyme inducing medications
boolean
C3830625 (UMLS CUI [1])
ketoconazole
Item
requirement for ketoconazole or other strong inhibitor of cyp3a4 enzymes
boolean
C0022625 (UMLS CUI [1])
chemotherapy, immunotherapy
Item
prior chemotherapy, immunotherapy, investigational agent, or other therapy used to treat the cancer within 4 weeks (6 weeks for prior treatment with mitomycin c or nitrosoureas) prior to the scheduled administration of ezn-2208
boolean
C0392920 (UMLS CUI [1])
C0021083 (UMLS CUI [2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial